The Emergency Responders Mental Health Training Act directs the Secretary of Health and Human Services to create a pilot fellowship program that funds postbaccalaureate training for mental health and substance use disorder professionals. This initiative aims to increase the number of culturally competent practitioners who understand the unique stressors, duties, and confidentiality requirements faced by emergency response providers such as police, firefighters, and EMTs. The bill authorizes $10 million in annual appropriations for fiscal years 2028 through 2033 to support these fellowships across fields including psychiatry, nursing, social work, and psychology. Additionally, the Secretary must submit reports to Congress two and five years after the program's establishment to evaluate its efficiency, impact on patient outcomes, and overall effectiveness.
This House resolution formally recognizes suicide as a serious public health problem in the United States and expresses support for designating September 2026 as National Suicide Prevention Month and September 10, 2026, as World Suicide Prevention Day. The bill cites data from the CDC, SAMHSA, and the VA to highlight that suicide is a leading cause of death among young people, veterans, and during the postpartum period, while also noting the significant economic costs associated with it. It declares suicide prevention a national priority and emphasizes that mental health is as important as physical health. The resolution supports the development of strategies to improve access to quality mental health, substance abuse, and suicide prevention services for all communities.
The MORE Savings Act aims to reduce financial barriers for individuals seeking treatment for opioid use disorders by eliminating out-of-pocket costs for specific services. For Medicare beneficiaries, it establishes a five-year pilot program in 15 selected states that removes coinsurance, copayments, and deductibles for prescription drugs, behavioral health care, and community recovery support. Additionally, the bill mandates that private group health plans and individual insurance policies cover these same opioid treatments without cost-sharing requirements starting in 2027. Finally, it increases the federal funding match to 90 percent for states providing medication-assisted treatment through Medicaid and allows states to include recovery support services in this coverage.
This House resolution formally recognizes Overdose Awareness Day in the United States and calls for strengthened efforts to combat the opioid crisis. It directs the House of Representatives to pursue bipartisan legislation aimed at reducing the stigma associated with substance use disorders and drug overdoses. Additionally, the bill commits lawmakers to work with state and local governments, businesses, and health care providers to build a comprehensive system that supports prevention, treatment, harm reduction, and recovery for individuals affected by opioid use disorder.
Pennsylvania House Bill 2749 amends the state's Controlled Substance, Drug, Device and Cosmetic Act to expand legal protections for individuals and entities involved in responding to opioid overdoses. The bill grants immunity from criminal prosecution, civil liability, and professional disciplinary action to licensed health care professionals who prescribe or dispense opioid antagonists, including naloxone, as long as they act in good faith. It also extends similar protections to first responders, law enforcement, and private citizens who administer these medications to people they believe are suffering an overdose. Additionally, the legislation allows municipalities, local health departments, and community organizations to distribute expired opioid antagonists without facing legal liability, provided the medication is less than five years past its expiration date.
Pennsylvania House Bill 2731 directs the Department of Drug and Alcohol Programs to work with the Department of General Services to procure opioid antagonists through a competitive process. The bill mandates that cost-effectiveness must account for at least 90% of the decision-making weight, while also considering product efficacy, availability, brand type, and shelf life. Additionally, it requires the department to submit an annual report on the procurement strategy and vendor selection to legislative committee leaders starting in 2028.
This resolution declares September 12, 2026, as Recovery Day in Michigan to honor individuals working toward long-term sobriety and the organizations that support them. It highlights the gap between the number of residents with substance use disorders and those receiving treatment, emphasizing the role of recovery community groups in providing ongoing assistance at a lower cost than clinical care. The measure also directs that a copy of the resolution be sent to the Blue Water Recovery and Outreach Center as a gesture of appreciation.
This bill is a procedural resolution that proclaims September 2026 as Recovery Month in California. It aims to honor individuals in recovery, service providers, and communities dedicated to treating substance use disorders and mental health conditions. The text also highlights recent state investments under Proposition 1, which have funded new behavioral health facilities and treatment slots across the state.
The Campus Lifeline Act expands federal grant programs to support student-led mental health and substance use disorder interventions at institutions of higher education. It authorizes funding for peer awareness activities, such as suicide prevention education and digital campaigns that encourage students to seek help, while requiring grantees to provide accessible resources for online and distance-learning students. Additionally, the bill directs the National Suicide Prevention Lifeline program to coordinate with schools and universities to list hotline numbers on student identification cards and promote behavioral health resources through public service announcements.
The RCORP Authorization Act establishes a new program to provide funding for preventing, treating, and recovering from opioid and other substance use disorders in rural areas. This program allows the Health Resources and Services Administration to award grants to states, tribal organizations, and other eligible entities for up to five years. The funds can be used for planning, implementing evidence-based treatment models, addressing emerging public health issues, and providing technical assistance, but they cannot be used to buy or improve real property. The legislation authorizes $165 million annually for each fiscal year from 2027 through 2031 to support these efforts.
